Patents by Inventor Tobias Jürgen Erb

Tobias Jürgen Erb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220315942
    Abstract: The present invention relates to transgenic plants with altered photorespiration and improved CO2 fixation as well as a method of producing said transgenic plants. Particularly, the transgenic plants show an improved growth rate, productivity and energy conversion efficiency. This method can be successfully applied to many agricultural crop plants with nutritional and medicinal uses.
    Type: Application
    Filed: August 5, 2020
    Publication date: October 6, 2022
    Applicants: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., Heinrich-Heine-Universität Düsseldorf
    Inventors: Lennart Schada Von Borzyskowski, Tobias Jürgen Erb, Andreas Paul Michael Weber, Marc-Sven Roll
  • Publication number: 20220145339
    Abstract: The present invention relates to an enzyme-catalyzed enantioselective method for preparing primary amines from the corresponding imines by using imine reductase enzymes.
    Type: Application
    Filed: December 9, 2019
    Publication date: May 12, 2022
    Inventors: Lennart Schada Von Borzyskowski, Tobias Jürgen Erb
  • Publication number: 20210163956
    Abstract: The present invention relates to autotrophic microorganisms with altered photorespiration and improved CO2 fixation as well as a method of producing said autotrophic microorganisms. Particularly, the autotrophic microorganisms show an improved growth rate, productivity and energy conversion efficiency.
    Type: Application
    Filed: April 15, 2019
    Publication date: June 3, 2021
    Inventors: Lennart Schada Von Borzyskowski, Tobias Jürgen Erb, Jan Zarzycki
  • Publication number: 20100190224
    Abstract: The present invention relates to an isolated DNA, which is selected from the following sequences: a) a sequence according to SEQ ID No. 01, b) an intron-free sequence that is derived from a sequence according to a) and encodes the same protein or peptide as the sequence according to SEQ ID No. 01, c) a sequence that encodes a protein or peptide, which comprises the amino acid sequence according to SEQ ID No. 02, d) a sequence that is at least 80% identical to a sequence according to a) to c), e) a sequence that hybridizes with the antisense strand of a sequence according to one of the groups a) to d) or would hybridize taking into account degeneration of the genetic code, f) a derivative of a sequence according to one of the groups a) to e) obtained by substitution, addition, inversion and/or deletion of one or more bases, g) a sequence that corresponds to SEQ ID No. 01 within the degeneration of the genetic code, h) a sequence with neutral sense mutations of SEQ ID No.
    Type: Application
    Filed: March 27, 2008
    Publication date: July 29, 2010
    Applicants: EVONIK DEGUSSA Gmbh, ALBERT-LUDWIG-UNIVERSITAET FREIBURG
    Inventors: Markus Poetter, Achim Marx, Georg Fuchs, Birgit Alber, Tobias Juergen Erb